Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
Kinco Automation (Shanghai) Co.,Ltd
688160
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 13.780
- +0.510+3.84%
Close Jan 22 16:00 ET
- 13.780
- 0.0000.00%
Post 16:02 ET
504.02MMarket Cap-7.02P/E (TTM)
14.100High13.150Low104.71KVolume13.160Open13.270Pre Close1.42MTurnover0.71%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High1.56P/B204.35MFloat Cap12.09552wk Low--Dividend TTM14.83MShs Float29.740Historical High--Div YieldTTM7.16%Amplitude12.095Historical Low13.573Avg Price1Lot Size
About Rapport Therapeutics Company
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Company Profile
SymbolRAPP
Company NameRapport Therapeutics
Listing DateJun 7, 2024
Issue Price17.00
Founded2022
CEOMr. Abraham N. Ceesay, M.B.A.
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address1325 Boylston Street,Suite 401
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-321-8020
Websitehttp://www.rapportrx.com
Company Executives
- Name
- Position
- Salary
- Abraham N. Ceesay, M.B.A.
- Chief Executive Officer and Director
- 2.42M
- David Bredt, M.D.,PhD
- Chief Scientific Officer and Director
- --
- Dr. Bradley S. Galer, M.D.
- Chief Medical Officer
- --
- Dr. Swamy Yeleswaram, PhD
- Chief Development Officer
- --
- Troy A. Ignelzi
- Chief Financial Officer
- 2.13M
- Kathy Wilkinson
- Chief People Officer
- --
- Cheryl Gault
- Chief Operating Officer
- 1.78M
- Dr. Steven M. Paul, M.D.
- Chairman of the Board
- 568.99K
- Dr. Reid M. Huber, PhD
- Director
- 400.26K
- Terry-Ann Burrell, M.B.A.
- Director
- --
- Dr. John M. Maraganore,PhD
- Director
- --
- Dr. James I. Healy, M.D.,PhD
- Director
- --
- Raymond Kelleher, M.D.,PhD
- Director
- --
- Dr. Jeffrey K. Tong, PhD
- Director
- 55.50K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart